Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$6,842,981
-$224,981 QoQ
Shares Held
18,897
-5.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#688
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. AMGN ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
This page
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,842,981 | 18,897 | Shares | Other | 2026-07-08 | |
| 2026-03-31 | $7,067,962 | 20,088 | Shares | Other | 2026-04-13 | |
| 2025-12-31 | $6,599,223 | 20,162 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $4,965,873 | 17,597 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $5,575,823 | 19,970 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $6,170,870 | 19,807 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $5,031,655 | 19,305 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $6,096,857 | 18,922 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,857,812 | 18,748 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $5,392,128 | 18,965 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,293,519 | 18,379 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $4,563,544 | 16,980 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,090,518 | 13,920 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $3,365,160 | 13,920 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $3,667,767 | 13,965 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,154,473 | 13,995 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $3,436,612 | 14,125 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,420,543 | 14,145 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,165,327 | 14,070 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $2,763,386 | 12,995 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $3,168,750 | 13,000 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $14,612,362 | 58,729 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $13,485,727 | 58,654 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $3,430,651 | 13,498 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $3,216,658 | 13,638 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,816,527 | 13,893 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||